Skip to main content

FDA Pregnancy Category

  • Reference work entry
  • 85 Accesses

Definition

Category A: Controlled studies show no risk: adequate, well-controlled studies in pregnant women have failed to demonstrate risk to the fetus. B: No evidence of risk in humans: either animal studies show risk, but human findings do not; or, if no adequate human studies have been performed, animal findings are negative. C: Risk cannot be ruled out: human studies are lacking and animal studies are either positive for fetal risk or lacking as well. However, potential benefits may outweigh risks. D: Positive evidence of risk: investigational or postmarketing data show risk to the fetus. Nevertheless, potential benefits may outweigh risks. X: Contraindicated in pregnancy: studies in animals or humans, or investigational or postmarketing reports, have shown fetal risks that clearly outweigh any possible benefit to the patient.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   749.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Preskorn, S., Dahmen, M.M., Lincoln, J. (2010). FDA Pregnancy Category. In: Stolerman, I.P. (eds) Encyclopedia of Psychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68706-1_758

Download citation

Publish with us

Policies and ethics